Skip to main content
Log in

Maraviroc moderates a mint in Mexico

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Contreras-Hernandez I, Rely K, Mould-Quevedo J, Davila-Loaiza G.The economic impact of maraviroc for antiretroviral treatment-experienced HIV-infected individuals in Mexico. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 116 abstr. PIN36, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com

  2. Contreras-Hernandez I, Becker DL, Chancellor JV, Kühne F, Mould-Quevedo J, Marfatia S.Cost-effectiveness of maraviroc for HIV in Mexico. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 116 abstr. PIN35, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maraviroc moderates a mint in Mexico. Pharmacoecon. Outcomes News 579, 6 (2009). https://doi.org/10.2165/00151234-200905790-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905790-00008

Keywords

Navigation